Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)

Conditions

• COVID-19

Interventions

• BIOLOGICAL: GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation